The Director, National Accounts will lead strategic engagement with key payer accounts to ensure access to Scholar Rock's drug apitegromab, significantly impacting patient access and company launch success.
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.
Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.
Summary of Position:
The Director, National Accounts role is an opportunity for an experienced payer account executive to help launch apitegromab, Scholar Rock’s investigational drug for the treatment of Spinal Muscular Atrophy (SMA). This team will have a direct impact on our ability to deliver value to patients and the trajectory of the company’s first launch. This role will be accountable for establishing Scholar Rock’s presence with key payers, achieving rapid, appropriate coverage for apitegromab in assigned accounts and regions, and supporting ongoing patient access efforts through launch.
Position Responsibilities:
- Lead account planning, management, and engagement activities at assigned payers to achieve rapid and clinically appropriate access for patients. This includes establishing and further developing relationships with decision makers at key customers
- Support development of apitegromab’s value proposition and other supporting materials, including any account-specific needs
- Maintain a strong understanding of apitegromab Commercial objectives and how to help achieve these goals through assigned accounts
- Work across teams to ensure patient access objectives are met, including pull-through
- Ensure all programs are aligned to Scholar Rock values and remain compliant with regulations
- Lead presence with target accounts at access-related meetings, events and congresses (e.g., AMCP, PCMA, Asembia, Medicaid meetings, etc.)
- Collaborate with Insights and Analytics and Commercial Operations to derive account-level insights and actions; communicate access and coverage performance regularly to internal stakeholders
- Proactively identify and execute against opportunities to improve patient access to care, within and outside of Value & Access
- Be a content expert on relevant industry trends, market dynamics, policy and legislation and define implications and actions for Scholar Rock
- Be a collaborative, strategic market access presence throughout the Scholar Rock organization
Candidate Requirements:
- Bachelors degree or advanced degree
- At least 10 years’ experience in US Market Access with a deep understanding of evolving access, coverage, and reimbursement landscape
- 5 years+ National Account Experience with existing relationships with CVS/Zinc/Aetna preferred
- National Account contracting experience preferred
- Rare disease launch experience preferred
- Experience and relationships with national and key regional Commercial, Medicaid, MAC’s and other Government payers
- Proven track record of achieving rapid, broad, and clinically appropriate coverage for medical benefit and/or rare disease products at launch
- Comprehensive understanding of payer decision making bodies and cycles, processes/procedures, and data and reporting
- Experience negotiating agreements with large healthcare systems preferred
- Pre-launch experience at a small, start-up biotechnology company preferred
Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
Similar Jobs
Biotech • Pharmaceutical
The Director of National Accounts will develop strategies and manage relationships with key accounts to achieve sales targets and enhance market access for Regeneron products.
Top Skills:
Customer Relationship Management ToolsVeeva
Healthtech
This role involves managing key national accounts, driving market adoption of products, establishing sales targets, and providing leadership within a performance-based culture.
Cloud • Fintech • Food • Information Technology • Software • Hospitality
The RVP for Toast Retail Field Sales will lead a team in driving revenue and sales performance, focusing on talent development and operational excellence in the CPG space.
What you need to know about the Colorado Tech Scene
With a business-friendly climate and research universities like CU Boulder and Colorado State, Colorado has made a name for itself as a startup ecosystem. The state boasts a skilled workforce and high quality of life thanks to its affordable housing, vibrant cultural scene and unparalleled opportunities for outdoor recreation. Colorado is also home to the National Renewable Energy Laboratory, helping cement its status as a hub for renewable energy innovation.
Key Facts About Colorado Tech
- Number of Tech Workers: 260,000; 8.5% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Lockheed Martin, Century Link, Comcast, BAE Systems, Level 3
- Key Industries: Software, artificial intelligence, aerospace, e-commerce, fintech, healthtech
- Funding Landscape: $4.9 billion in VC funding in 2024 (Pitchbook)
- Notable Investors: Access Venture Partners, Ridgeline Ventures, Techstars, Blackhorn Ventures
- Research Centers and Universities: Colorado School of Mines, University of Colorado Boulder, University of Denver, Colorado State University, Mesa Laboratory, Space Science Institute, National Center for Atmospheric Research, National Renewable Energy Laboratory, Gottlieb Institute
